light sensitivity; nausea; vomiting; full migraine/severe migraine persisted for 9 hours; severe headache/Light headache in the morning and a more severe headache returning; Severe arm pain preventing sleep when sleeping on opposite side/pain 6/10; severe arm pain preventing sleep when sleeping on opposite side (left arm injection, sleeping on right side); skin sensitivity with tingling sensation on any touch to the skin; skin sensitivity with tingling sensation on any touch to the skin; Dose number: 3; fatigue; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 36 year-old female patient (not pregnant) received bnt162b2 (COMIRNATY), administered in arm left, administration date 20Dec2021 14:00 (Lot number: FH8027) at the age of 36 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Occipital Neuralgia" (unspecified if ongoing); "exercise-induced asthma" (unspecified if ongoing); "chronic bronchitis" (unspecified if ongoing); "Covid" (unspecified if ongoing), notes: if covid prior vaccination: Yes. Concomitant medication(s) included: ETONOGESTREL. Past drug history included: Aspartame, reaction(s): "Allergy: aspartame (Headaches, Nausea)", notes: known allergies: aspartame (headaches, nausea); Aspartame, reaction(s): "Allergy: aspartame (Headaches, Nausea)", notes: known allergies: aspartame (headaches, nausea); Percocet, reaction(s): "Allergy: Percoset (Nausea, vomiting, hives)", notes: known allergies: Percoset (nausea, vomiting, hives),; Percocet, reaction(s): "Allergy: Percoset (Nausea, vomiting, hives)", notes: known allergies: Percoset (nausea, vomiting, hives),; Percocet, reaction(s): "Allergy: Percoset (Nausea, vomiting, hives)", notes: known allergies: Percoset (nausea, vomiting, hives),. Vaccination history included: Comirnaty (First Dose, lot number: EL3247, vaccine location: Left arm), administration date: 10Mar2021, when the patient was 35 years old, for Covid-19 Immunization; Comirnaty (Second Dose, lot number: EP6955, vaccine location: Left arm), administration date: 31Mar2021, when the patient was 35 years old, for Covid-19 Immunization. The following information was reported: IMMUNISATION (non-serious) with onset 20Dec2021 14:00, outcome "unknown", described as "Dose number: 3"; PAIN IN EXTREMITY (non-serious) with onset 21Dec2021 03:00, outcome "unknown", described as "Severe arm pain preventing sleep when sleeping on opposite side/pain 6/10"; SLEEP DISORDER (non-serious) with onset 21Dec2021 03:00, outcome "unknown", described as "severe arm pain preventing sleep when sleeping on opposite side (left arm injection, sleeping on right side)"; HEADACHE (non-serious) with onset 21Dec2021 12:00, outcome "recovered" (22Dec2021 18:00), described as "severe headache/Light headache in the morning and a more severe headache returning"; MIGRAINE (non-serious) with onset 21Dec2021 14:00, outcome "recovered" (21Dec2021 23:00), described as "full migraine/severe migraine persisted for 9 hours"; PHOTOPHOBIA (non-serious) with onset 21Dec2021 15:00, outcome "recovered" (21Dec2021 16:00), described as "light sensitivity"; NAUSEA (non-serious) with onset 21Dec2021 15:00, outcome "recovered" (21Dec2021 16:00), described as "nausea"; VOMITING (non-serious) with onset 21Dec2021 15:00, outcome "recovered" (21Dec2021 16:00), described as "vomiting"; FATIGUE (non-serious) with onset Dec2021, outcome "unknown", described as "fatigue"; PARAESTHESIA (non-serious), SENSITIVE SKIN (non-serious) all with onset 21Dec2021, outcome "recovered" (Dec2021) and all described as "skin sensitivity with tingling sensation on any touch to the skin". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pain in extremity, sleep disorder, headache, migraine, photophobia, nausea, vomiting, fatigue, paraesthesia, sensitive skin.   The patient didn't received any other vaccines within 4 weeks prior to the COVID vaccine List of any other medications the patient received within 2 weeks of vaccination:Etonogestrel - EE Vaginal Ring .12/.015. Reported Event: 13 Hours post vaccination (3am) severe arm pain preventing sleep when sleeping on opposite side (left arm injection, sleeping on right side) - pain 6/10. 22 hours (12p) post vaccination severe headache onset worsening to full migraine by 24 hours (2p) with light sensitivity and nausea, vomiting at 25 hours (3p) lasted for 1 hour (until 4p), severe migraine persisted for 9 hours until Hour 33 (11p). 22H post vaccination also experienced skin sensitivity with tingling sensation on any touch to the skin, lasted approximately 1-2 hours. Mild headache and fatigue remained on 2nd day after booster, with a light headache in the morning and a more severe headache returning 48-51 hours/2-5p before ending around 6p. Yes, reported that covid prior vaccination. The patient had been tested for COVID-19 was no, Device Date : 22Dec2021  Follow-Up (04Jan2022): Follow-up attempts are completed. No further information is expected.